Skip to content
Peptigraph home
Shop Peptides50% off*

KLOW for Skin: What the Evidence Shows

What human and animal studies show about KLOW for skin, how strong that evidence is, and what is still unproven.

Medical review pendingFour-peptide blendUpdated
Strongest evidence
Human RCT
from an ingredient's studies
Human studies
5
with an outcome for skin, in our evidence file (PubMed search, 11 Oct 2026)
Animal studies
4
with an outcome for skin, in our evidence file (PubMed search, 11 Oct 2026)
Studies we summarised
16
with an outcome for skin

Evidence for skin

Each row is an outcome related to skin from a published study, strongest design first. Animal and cell results are labelled and are not human results. User reports are not counted as evidence here. No study has tested KLOW itself; rows are for each ingredient.

KLOW for skin: outcomes in published studies
OutcomeResultStudy typeSource
TB-500: Scalp seborrheic dermatitisThe thymosin beta-4 gel was reported more effective than ketoconazole lotion for scalp seborrheic dermatitis (randomization not stated in abstract).Human controlled trialn = 71Microbial biotechnology 2021, PMID 34318587
TB-500: Wound healingPhase 2 findings suggest a 0.03% dose may accelerate healing, with complete healing within 3 months in about 25% of patients, mainly those with smaller or milder ulcers.Human RCTn = 73Annals of the New York Academy of Sciences 2010, PMID 20536470
GHK-Cu: Erythema resolutionNo significant difference between groups in erythema resolution on computer analysis and blinded evaluation.Human RCTn = 13Archives of facial plastic surgery 2006, PMID 16847171
GHK-Cu: Patient-reported skin qualityPatients using GHK-Cu skin care products reported significantly greater improvement in overall skin quality (P = .04), but blinded and objective evaluation found no group difference in wrinkles or skin quality.Human RCTn = 13Archives of facial plastic surgery 2006, PMID 16847171
GHK-Cu: Plantar ulcer closureMedian ulcer area closure was 98.5% with the GHK-copper gel versus 60.8% with vehicle (p < 0.05).Human RCTWound repair and regeneration 1994, PMID 17147644
GHK-Cu: Ulcer infectionUlcer infections occurred in 7% with the gel versus 34% with vehicle among ulcers treated immediately after debridement (p < 0.05).Human RCTWound repair and regeneration 1994, PMID 17147644
GHK-Cu: Crow's feet wrinklesIn one patient, photographs showed greatly decreased wrinkles around the treated eye after a multi-ingredient cosmetic treatment.Human case reportn = 1Journal of cosmetic and laser therapy 2016, PMID 27064823
GHK-Cu: State of the human evidenceThe review states the human literature is thin and fragmented; most randomized trials are small facial cosmetic cream studies.Systematic reviewArchives of internal medicine research 2026, PMID 42787770
GHK-Cu: Clinical evidence for wrinklesThe review reports a surprising absence of clinical studies of GHK-Cu and Pal-GHK for wrinkles.ReviewBioImpacts 2025, PMID 39963574
TB-500: Phase 2 wound trialsThe review reports accelerated repair in phase 2 trials of pressure ulcers, stasis ulcers and epidermolysis bullosa wounds.ReviewVitamins and hormones 2016, PMID 27450738
GHK-Cu: Scald wound healing timeWound healing time was shortened to 14 days with GHK-Cu liposomes in mice.Animal · mouse (plus human umbilical vein endothelial cells) (not a human result)Wound repair and regeneration 2017, PMID 28370978
BPC-157: Laser wound healingTopical BPC 157 cream improved healing of laser skin injuries macroscopically and microscopically.Animal · mouse (not a human result)Burns 2005, PMID 15774286
GHK-Cu: Wound area reductionBy day 13 wound area had decreased by 64.5% with topical tripeptide-copper, 45.6% with vehicle and 28.2% in untreated controls.Animal · rat (not a human result)n = 24Veterinary surgery 2003, PMID 14648529
BPC-157: Burn wound healingBPC 157 cream-treated mice had improved burn healing parameters throughout the experiment compared with untreated controls.Animal · mouse (not a human result)Burns 2001, PMID 11718984
BPC-157: Re-epithelizationTwo weeks after injury, BPC 157 cream reversed the poor re-epithelization seen in untreated and vehicle-only mice.Animal · mouse (not a human result)Burns 2001, PMID 11718984
KPV: Keratinocyte viability and IL-1betaKPV at 50 ug/mL restored cell viability and reduced IL-1beta secretion in PM10-exposed keratinocytes.In vitro (not a human result)Tissue & cell 2025, PMID 40073467
KPV: Skin permeationKPV did not permeate human skin by passive diffusion alone (below the detection limit of 0.01 ug/mL); microneedles and iontophoresis were needed.In vitro (not a human result)Journal of pharmaceutical sciences 2017, PMID 28343991
KPV: Cyclic AMP signallingKPV did not raise cyclic AMP in human keratinocytes (mechanism study; no clinical outcome).In vitro (not a human result)The Journal of investigative dermatology 2004, PMID 15102092
GHK-Cu: TGF-beta1 secretionCopper tripeptide-treated fibroblasts secreted less TGF-beta1 than controls in cell culture.In vitro (not a human result)Archives of facial plastic surgery 2001, PMID 11176716

KLOW and skin are not in our PubMed count ledger yet; the rows above come from our evidence file (PubMed search, 11 Oct 2026). Grades follow our .

How strong is it?

Strongest evidence:Human RCT evidence, 4 of 4TB-500: Microbial biotechnology 2021, PMID 34318587

A human randomized trial outweighs any number of animal studies. Animal and cell results show a mechanism worth testing, not that it works in people.

Skin aging products, and what is approved

MedlinePlus says the FDA has approved only a few products for sun-damaged or aging skin.[17]

Skin outcomes reported for the GHK-Cu component

In a small randomized laser-resurfacing trial, GHK-Cu skin care did not change objective skin measures, but patients were more satisfied.[3]

A single patient treated with a copper-GHK cosmetic mix had higher procollagen and fibrillin in biopsies, which cannot be attributed to GHK-Cu alone.[5]

A review states that GHK is widely promoted for topical use but skin permeability data are lacking.[7]

A systematic review says human GHK-Cu trials are mostly small cosmetic-cream studies.[6]

In rat ischemic wounds, topical GHK-copper gel left wounds smaller than in vehicle or untreated groups on day 13.[11]

In lab-grown skin cells, copper tripeptide lowered TGF-beta1 secretion, which authors tie to scarring.[16]

A search for all four components together found 0 PubMed records on 2 Oct 2026, so the blend has no skin study.

Calculated from search GHK-Cu terms AND BPC-157 terms AND (TB-500 OR thymosin beta-4 terms) AND KPV terms; date 2026-10-02; count 0; page topic skin; source our combinations data ghk-cu__klow. Formula: records matching all four components = count = 0

Other peptides people research for skin

GHK-CuTirzepatideKPVBPC-157GLOWTB-500WolverineLL-37
All peptides for skin, compared

Common questions

Does KLOW help with skin?

The strongest study we summarise for skin is human rct evidence, for an ingredient rather than the blend, across 16 studies with an outcome for skin. A trial result is not an approval; see the legal status.

Is KLOW approved for skin?

No. KLOW is not FDA approved for any use, including skin.

What is the best peptide for skin?

There is no single answer. Our skin overview compares each candidate by evidence grade and legal status rather than by popularity.

Is KLOW good for eczema or loose skin?

No cached study tests the blend on eczema or loose skin; the closest controlled human trial of a component, in laser-resurfaced skin, found no objective difference in redness.[3]

More on KLOW

DosageDoses used in published studies, with the source for each.Blend calculatorSplit a blend vial into per-peptide amounts and units.Side effectsWhat labels and studies report, and what is unknown.ResultsStudy outcomes and when they were measured.PricePrice per mg and per week from dated listings. No vendor links.Legal statusFDA, compounding and WADA status with dates.

Sources

  1. 1Recombinant human thymosin beta-4 (rhTβ4) improved scalp condition and microbiome homeostasis in seborrheic dermatitis.Microbial biotechnology · 2021PMID 34318587Accessed 2 Oct 2026
  2. 2The effect of thymosin treatment of venous ulcers.Annals of the New York Academy of Sciences · 2010PMID 20536470Accessed 2 Oct 2026
  3. 3Effects of topical copper tripeptide complex on CO2 laser-resurfaced skin.Archives of facial plastic surgery · 2006PMID 16847171Accessed 2 Oct 2026
  4. 4Enhanced healing of ulcers in patients with diabetes by topical treatment with glycyl-l-histidyl-l-lysine copper.Wound repair and regeneration : official publication of the Wound Healing Society [and] the European Tissue Repair Society · 1994PMID 17147644Accessed 2 Oct 2026
  5. 5Significant improvement in crow's feet after treatment with Jet-M and a mixed solution of copper-GHK, oligo-hyaluronic acid, rhodiolar extract, tranexamic acid, and β-glucan (GHR formulation).Journal of cosmetic and laser therapy : official publication of the European Society for Laser Dermatology · 2016PMID 27064823Accessed 2 Oct 2026
  6. 6A Systematic Review of the Mechanisms and Therapeutic Applications of GHK-Cu (Glycyl-L-Histidyl-L-Lysine-Copper Complex) in Topical Microneedle Delivery: A Case for Expanded Clinical Trials.Archives of internal medicine research · 2026PMID 42787770Accessed 2 Oct 2026
  7. 7Topically applied GHK as an anti-wrinkle peptide: Advantages, problems and prospective.BioImpacts : BI · 2025PMID 39963574Accessed 2 Oct 2026
  8. 8Thymosin β4 Promotes Dermal Healing.Vitamins and hormones · 2016PMID 27450738Accessed 2 Oct 2026
  9. 9GHK-Cu-liposomes accelerate scald wound healing in mice by promoting cell proliferation and angiogenesis.Wound repair and regeneration : official publication of the Wound Healing Society [and] the European Tissue Repair Society · 2017PMID 28370978Accessed 2 Oct 2026
  10. 10The stable gastric pentadecapeptide BPC 157, given locally, improves CO2 laser healing in mice.Burns : journal of the International Society for Burn Injuries · 2005PMID 15774286Accessed 2 Oct 2026
  11. 11The effect of topical tripeptide-copper complex on healing of ischemic open wounds.Veterinary surgery : VS · 2003PMID 14648529Accessed 2 Oct 2026
  12. 12Pentadecapeptide BPC 157 cream improves burn-wound healing and attenuates burn-gastric lesions in mice.Burns : journal of the International Society for Burn Injuries · 2001PMID 11718984Accessed 2 Oct 2026
  13. 13Lysine-Proline-Valine peptide mitigates fine dust-induced keratinocyte apoptosis and inflammation by regulating oxidative stress and modulating the MAPK/NF-κB pathway.Tissue & cell · 2025PMID 40073467Accessed 2 Oct 2026
  14. 14Transdermal Iontophoretic Delivery of Lysine-Proline-Valine (KPV) Peptide Across Microporated Human Skin.Journal of pharmaceutical sciences · 2017PMID 28343991Accessed 2 Oct 2026
  15. 15alpha-Melanocyte-stimulating hormone, MSH 11-13 KPV and adrenocorticotropic hormone signalling in human keratinocyte cells.The Journal of investigative dermatology · 2004PMID 15102092Accessed 2 Oct 2026
  16. 16The effect of copper tripeptide and tretinoin on growth factor production in a serum-free fibroblast model.Archives of facial plastic surgery · 2001PMID 11176716Accessed 2 Oct 2026
  17. 17Official web pageOfficial web page · web page

Found an error? Report a correction.